Follow-on Prompt:
What is the scientific and clinical evidence that the liposomal formulations of Hesperidin from the primary CELLg8 manufacturer (Valimenta/Cellure) have greater bioavailability than the non-lipisomal versions, how good is that evidence, and what is the level of validation on the level of increased bioavailability of these liposomal formulations of Hesperidin?
Gemini Pro Response
Executive Summary: The Evidence Gap
Direct Answer: There is zero direct, peer-reviewed clinical evidence specifically validating the bioavailability of CELLg8 Hesperidin in humans.
While the CELLg8 delivery system (the “platform”) is validated for other nutrients (Vitamin C, Green Tea, B12), Valimenta/Cellure has not published a specific study on Hesperidin. The claims of “superior bioavailability” for their Hesperidin are extrapolations based on their data for chemically similar polyphenols (specifically Green Tea/EGCG).
Detailed Scientific Analysis
1. The Evidence Hierarchy for CELLg8 Hesperidin
| Evidence Level |
Description |
Status for CELLg8 Hesperidin |
| Level 1 |
Peer-reviewed human trial of CELLg8 Hesperidin vs. Standard Hesperidin |
NON-EXISTENT |
| Level 2 |
Unpublished white paper / Internal data for CELLg8 Hesperidin |
Likely Exists (Not Public) |
| Level 3 |
“Platform” validation (CELLg8 works for other molecules) |
STRONG (Published) |
| Level 4 |
General scientific consensus (Liposomes improve flavonoids) |
STRONG |
2. The “Platform” Extrapolation (The “Proxy” Evidence)
Since direct data is missing, manufacturers (like Renue By Science) rely on “Proxy Validation”—using data from structurally similar molecules to infer efficacy.
-
The Best Proxy: Green Tea Extract (EGCG)
-
Why it matters: EGCG is a polyphenol, chemically similar to Hesperidin (both are large, poorly soluble flavonoid molecules).
-
The Data: A CELLg8 study on Green Tea Extract showed a ~10-fold (10x) increase in plasma concentration of catechins compared to standard extract.
-
The Inference: Because CELLg8 worked exceptionally well for EGCG (another difficult-to-absorb flavonoid), it is scientifically plausible—though unproven—that it would achieve similar results for Hesperidin.
-
The Weaker Proxy: Vitamin C
-
The Data: CELLg8 Vitamin C studies show a ~20-50% increase in bioavailability over standard Vitamin C.
-
Why it’s less relevant: Vitamin C is water-soluble and small; Hesperidin is poorly soluble and large. The mechanism of absorption is different, so Vitamin C data is a poor predictor for Hesperidin efficacy.
3. General Liposomal Validation (Non-CELLg8)
Independent science confirms that generic liposomal encapsulation significantly improves Hesperidin delivery.
-
Bioavailability Problem: Standard Hesperidin has extremely poor oral bioavailability (<25%) because it is unstable in gastric acid and poorly soluble.
-
Liposomal Solution: Studies on generic liposomal hesperidin (not specifically CELLg8) have shown plasma concentrations 2-3x higher than standard powder in animal models.
Final Verification Grade
-
Technology Validation: HIGH. The CELLg8 liposomal manufacturing process (using non-hydrogenated sunflower phosphatidylcholine) is well-regarded and verified by electron microscopy (TEM) to create true liposomes (not just emulsions).
-
Specific Product Validation: LOW. The specific “CELLg8 Hesperidin” combination lacks a dedicated public clinical trial.
Academic Consensus: If you purchase CELLg8 Hesperidin, you are buying a high-quality, validated delivery system (CELLg8) applied to a theoretically ideal candidate (Hesperidin), but the specific “10x” or “20x” absorption claim is an extrapolation, not a measured fact for this specific ingredient.
So, the issue with this specific liposomal formulation is that it seems that they price the product at almost the same level as if the “multiplier” is a proven fact (which it isn’t) and so from a functional standpoint the cost per “100mg bioavailable Hesperidin” may be similar whether you buy the regular powder, or the Lipo Hesperidin that is priced 600% higher than the regular stuff. We “know” that they charge 600% more than the non-LIPO products, and they “say” that its 10X more bioavailable, but there is no 3rd party, independent verification of that claim (businesses are free to claim whatever they want in the supplement world, and its not like the pharma business where people validate their claims).
See below, it seems that the cost per 100mg of “bioavailable hesperidin” (the amount your body actually gets) - is still much, much cheaper via the bulk powder. Sure, you have to take 1 gram to get the equivalent of “100mg of the Lipo formulation”, but swallowing 1 gram vs. 100mg is not a significant difference to me, what I really care about is the Cost/100mg of bioavailable hesperidin.
The Master Comparison Table
| Product |
Raw Cost / 100mg |
Bioavailability Multiplier (Est.) |
Effective Cost per Bioavailable 100mg |
Cost Ratio (vs Bulk) |
| BulkSupplements Powder (1kg) |
$0.0053 |
1.0x |
$0.0053 |
1x (Baseline) |
| BulkSupplements Powder (100g) |
$0.0170 |
1.0x |
$0.0170 |
3.2x |
| Doctor’s Best HMC |
$0.0833 |
3.0x |
$0.0277 |
5.2x |
| Renue Lipo Hesperidin |
$0.1851 |
6.0x |
$0.0308 |
5.8x |
Full Gemini Pro Deep Search Analysis: https://gemini.google.com/share/f51c7e69afed